_id
691311b8ccc777a4e85d7ef0
Ticker
LVTX
Name
LAVA Therapeutics NV
Exchange
NASDAQ
Address
Yalelaan 62, Utrecht, Netherlands, 3584 CM
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.lavatherapeutics.com
Description
LAVA Therapeutics N.V. operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 which are preclinical candidates for the treatment of various hematologic malignancies. The company has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. LAVA Therapeutics N.V. was incorporated in 2016 and is based in Utrecht, the Netherlands.
Last Close
1.74
Volume
-
Current Price
1.74
Change
0
Last Updated
2025-12-02T11:28:13.194Z
Image
data:image/webp;base64,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
Ipo Date
2021-03-25T00:00:00.000Z
Market Cap
45771216
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9751999999999998
Sentiment Sources
5
Rating
3.5
Target Price
1.5054
Strong Buy
1
Buy
0
Hold
3
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
7553000
Operating Income
-7553000
Interest Expense
0
Pretax Income
-7182000
Net Income
-7188000
Eps
-0.2672206178328051
Dividends Per Share
-
Shares Outstanding
26305295
Income Tax Expense
6000
EBITDA
-7179000
Operating Margin
-
Total Other Income Expense Net
371000
Cash
49664000
Short Term Investments
0
Receivables
-
Inventories
-
Total Current Assets
51905000
Property Plant Equipment
0
Total Assets
51915000
Payables
1698000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
39231000
Equity
12684000
Depreciation
3000
Change In Working Capital
-200000
Cash From Operations
-4868000
Capital Expenditures
0
Cash From Investing
27702000
Cash From Financing
0
Net Change In Cash
23284000
PE
-
PB
3.6900403878902557
ROE
-56.66982024597919
ROA
-13.845709332562844
FCF
-4868000
Fcf Percent
-
Piotroski FScore
1
Health Score
20
Deep Value Investing Score
3
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
4
Quality Investing Score
1
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
7553000
Quarters > 0 > income Statement > operating Income
-7553000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-7182000
Quarters > 0 > income Statement > net Income
-7188000
Quarters > 0 > income Statement > eps
-0.2672206178328051
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
26899122
Quarters > 0 > income Statement > income Tax Expense
6000
Quarters > 0 > income Statement > EBITDA
-7179000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
371000
Quarters > 0 > balance Sheet > cash
49664000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
51905000
Quarters > 0 > balance Sheet > property Plant Equipment
0
Quarters > 0 > balance Sheet > total Assets
51915000
Quarters > 0 > balance Sheet > payables
1698000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
39231000
Quarters > 0 > balance Sheet > equity
12684000
Quarters > 0 > cash Flow > net Income
-7188000
Quarters > 0 > cash Flow > depreciation
3000
Quarters > 0 > cash Flow > change In Working Capital
-200000
Quarters > 0 > cash Flow > cash From Operations
-4868000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
27702000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
23284000
Quarters > 0 > ratios > PE
-0.2672206178328051
Quarters > 0 > ratios > PB
3.6900403878902557
Quarters > 0 > ratios > ROE
-56.66982024597919
Quarters > 0 > ratios > ROA
-13.845709332562844
Quarters > 0 > ratios > FCF
-4868000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
8000
Quarters > 1 > income Statement > gross Profit
-8000
Quarters > 1 > income Statement > operating Expenses
7289000
Quarters > 1 > income Statement > operating Income
-7289000
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-8567000
Quarters > 1 > income Statement > net Income
-8639000
Quarters > 1 > income Statement > eps
-0.3211628989228719
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
26899122
Quarters > 1 > income Statement > income Tax Expense
72000
Quarters > 1 > income Statement > EBITDA
-8559000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-1278000
Quarters > 1 > balance Sheet > cash
26380000
Quarters > 1 > balance Sheet > short Term Investments
29789000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
60495000
Quarters > 1 > balance Sheet > property Plant Equipment
43000
Quarters > 1 > balance Sheet > total Assets
60547000
Quarters > 1 > balance Sheet > payables
1428000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
40612000
Quarters > 1 > balance Sheet > equity
19935000
Quarters > 1 > cash Flow > net Income
-8639000
Quarters > 1 > cash Flow > depreciation
8000
Quarters > 1 > cash Flow > change In Working Capital
-4978000
Quarters > 1 > cash Flow > cash From Operations
-13749000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-2497000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-13294000
Quarters > 1 > ratios > PE
-0.3211628989228719
Quarters > 1 > ratios > PB
2.3478541399548534
Quarters > 1 > ratios > ROE
-43.335841484825686
Quarters > 1 > ratios > ROA
-14.268254413926371
Quarters > 1 > ratios > FCF
-13749000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
28
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
107000
Quarters > 2 > income Statement > gross Profit
-107000
Quarters > 2 > income Statement > operating Expenses
7588000
Quarters > 2 > income Statement > operating Income
-7588000
Quarters > 2 > income Statement > interest Expense
129000
Quarters > 2 > income Statement > pretax Income
-3254000
Quarters > 2 > income Statement > net Income
-3479000
Quarters > 2 > income Statement > eps
-0.12936656307549574
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
26892575
Quarters > 2 > income Statement > income Tax Expense
225000
Quarters > 2 > income Statement > EBITDA
-3018000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
4334000
Quarters > 2 > balance Sheet > cash
39674000
Quarters > 2 > balance Sheet > short Term Investments
26883000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
69780000
Quarters > 2 > balance Sheet > property Plant Equipment
1281000
Quarters > 2 > balance Sheet > total Assets
71156000
Quarters > 2 > balance Sheet > payables
1520000
Quarters > 2 > balance Sheet > short Term Debt
306000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
45372000
Quarters > 2 > balance Sheet > equity
25784000
Quarters > 2 > cash Flow > net Income
-3479000
Quarters > 2 > cash Flow > depreciation
107000
Quarters > 2 > cash Flow > change In Working Capital
-3638000
Quarters > 2 > cash Flow > cash From Operations
-11645000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
15159000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
4659000
Quarters > 2 > ratios > PE
-0.12936656307549574
Quarters > 2 > ratios > PB
1.8148107547316166
Quarters > 2 > ratios > ROE
-13.492863791498605
Quarters > 2 > ratios > ROA
-4.889257406262297
Quarters > 2 > ratios > FCF
-11645000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
32
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
4990000
Quarters > 3 > income Statement > cost Of Revenue
24550000
Quarters > 3 > income Statement > gross Profit
-19560000
Quarters > 3 > income Statement > operating Expenses
-12464000
Quarters > 3 > income Statement > operating Income
-7096000
Quarters > 3 > income Statement > interest Expense
515000
Quarters > 3 > income Statement > pretax Income
-3590000
Quarters > 3 > income Statement > net Income
-3970000
Quarters > 3 > income Statement > eps
-0.1477652955598092
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
26866931
Quarters > 3 > income Statement > income Tax Expense
380000
Quarters > 3 > income Statement > EBITDA
-3109000
Quarters > 3 > income Statement > operating Margin
-142.20440881763528
Quarters > 3 > income Statement > total Other Income Expense Net
3506000
Quarters > 3 > balance Sheet > cash
35015000
Quarters > 3 > balance Sheet > short Term Investments
41561000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
79297000
Quarters > 3 > balance Sheet > property Plant Equipment
1443000
Quarters > 3 > balance Sheet > total Assets
80831000
Quarters > 3 > balance Sheet > payables
2722000
Quarters > 3 > balance Sheet > short Term Debt
5201000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
53086000
Quarters > 3 > balance Sheet > equity
27745000
Quarters > 3 > cash Flow > net Income
-4220000
Quarters > 3 > cash Flow > depreciation
-220000
Quarters > 3 > cash Flow > change In Working Capital
3793000
Quarters > 3 > cash Flow > cash From Operations
-1405000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
10971000
Quarters > 3 > cash Flow > cash From Financing
-206000
Quarters > 3 > cash Flow > net Change In Cash
8052000
Quarters > 3 > ratios > PE
-0.1477652955598092
Quarters > 3 > ratios > PB
1.6849327785186519
Quarters > 3 > ratios > ROE
-14.308884483690756
Quarters > 3 > ratios > ROA
-4.911481980923161
Quarters > 3 > ratios > FCF
-1405000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.281563126252505
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
11982000
Annuals > 0 > income Statement > cost Of Revenue
467000
Annuals > 0 > income Statement > gross Profit
11982000
Annuals > 0 > income Statement > operating Expenses
41675000
Annuals > 0 > income Statement > operating Income
-29693000
Annuals > 0 > income Statement > interest Expense
515000
Annuals > 0 > income Statement > pretax Income
-24484000
Annuals > 0 > income Statement > net Income
-25114000
Annuals > 0 > income Statement > eps
-0.9358874955458328
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
26834422
Annuals > 0 > income Statement > income Tax Expense
630000
Annuals > 0 > income Statement > EBITDA
-23502000
Annuals > 0 > income Statement > operating Margin
-247.81338674678685
Annuals > 0 > income Statement > total Other Income Expense Net
5209000
Annuals > 0 > balance Sheet > cash
35015000
Annuals > 0 > balance Sheet > short Term Investments
41561000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
79297000
Annuals > 0 > balance Sheet > property Plant Equipment
1443000
Annuals > 0 > balance Sheet > total Assets
80831000
Annuals > 0 > balance Sheet > payables
2722000
Annuals > 0 > balance Sheet > short Term Debt
5201000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
53086000
Annuals > 0 > balance Sheet > equity
27745000
Annuals > 0 > cash Flow > net Income
-25114000
Annuals > 0 > cash Flow > depreciation
467000
Annuals > 0 > cash Flow > change In Working Capital
4383000
Annuals > 0 > cash Flow > cash From Operations
-19544000
Annuals > 0 > cash Flow > capital Expenditures
23000
Annuals > 0 > cash Flow > cash From Investing
12475000
Annuals > 0 > cash Flow > cash From Financing
-569000
Annuals > 0 > cash Flow > net Change In Cash
-9216000
Annuals > 0 > ratios > PE
-0.9358874955458328
Annuals > 0 > ratios > PB
1.6828940090106326
Annuals > 0 > ratios > ROE
-90.51721030816363
Annuals > 0 > ratios > ROA
-31.069762838514926
Annuals > 0 > ratios > FCF
-19567000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.6330328826573193
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
6769000
Annuals > 1 > income Statement > cost Of Revenue
3482000
Annuals > 1 > income Statement > gross Profit
3287000
Annuals > 1 > income Statement > operating Expenses
46681000
Annuals > 1 > income Statement > operating Income
-43394000
Annuals > 1 > income Statement > interest Expense
470000
Annuals > 1 > income Statement > pretax Income
-41614000
Annuals > 1 > income Statement > net Income
-41871000
Annuals > 1 > income Statement > eps
-1.5662924263583324
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
26732556
Annuals > 1 > income Statement > income Tax Expense
257000
Annuals > 1 > income Statement > EBITDA
-40532000
Annuals > 1 > income Statement > operating Margin
-641.0695819175654
Annuals > 1 > income Statement > total Other Income Expense Net
1780000
Annuals > 1 > balance Sheet > cash
44231000
Annuals > 1 > balance Sheet > short Term Investments
51340000
Annuals > 1 > balance Sheet > receivables
1699000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
98897000
Annuals > 1 > balance Sheet > property Plant Equipment
2494000
Annuals > 1 > balance Sheet > total Assets
101710000
Annuals > 1 > balance Sheet > payables
4446000
Annuals > 1 > balance Sheet > short Term Debt
5722000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
50532000
Annuals > 1 > balance Sheet > equity
51178000
Annuals > 1 > cash Flow > net Income
-41871000
Annuals > 1 > cash Flow > depreciation
612000
Annuals > 1 > cash Flow > change In Working Capital
-3876000
Annuals > 1 > cash Flow > cash From Operations
-40283000
Annuals > 1 > cash Flow > capital Expenditures
731000
Annuals > 1 > cash Flow > cash From Investing
-17636000
Annuals > 1 > cash Flow > cash From Financing
-571000
Annuals > 1 > cash Flow > net Change In Cash
-56102000
Annuals > 1 > ratios > PE
-1.5662924263583324
Annuals > 1 > ratios > PB
0.9088797420766735
Annuals > 1 > ratios > ROE
-81.81445152213843
Annuals > 1 > ratios > ROA
-41.16704355520598
Annuals > 1 > ratios > FCF
-41014000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-6.059092923622396
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
19391000
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
19391000
Annuals > 2 > income Statement > operating Expenses
54229000
Annuals > 2 > income Statement > operating Income
-34838000
Annuals > 2 > income Statement > interest Expense
82000
Annuals > 2 > income Statement > pretax Income
-31658000
Annuals > 2 > income Statement > net Income
-31907000
Annuals > 2 > income Statement > eps
-1.2307897641587402
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
25924005
Annuals > 2 > income Statement > income Tax Expense
249000
Annuals > 2 > income Statement > EBITDA
-30795000
Annuals > 2 > income Statement > operating Margin
-179.66066731989068
Annuals > 2 > income Statement > total Other Income Expense Net
3180000
Annuals > 2 > balance Sheet > cash
100333000
Annuals > 2 > balance Sheet > short Term Investments
32535000
Annuals > 2 > balance Sheet > receivables
3254000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
140533000
Annuals > 2 > balance Sheet > property Plant Equipment
2083000
Annuals > 2 > balance Sheet > total Assets
143425000
Annuals > 2 > balance Sheet > payables
3965000
Annuals > 2 > balance Sheet > short Term Debt
5019000
Annuals > 2 > balance Sheet > long Term Debt
4640000
Annuals > 2 > balance Sheet > total Liabilities
57385000
Annuals > 2 > balance Sheet > equity
86040000
Annuals > 2 > cash Flow > net Income
-31907000
Annuals > 2 > cash Flow > depreciation
781000
Annuals > 2 > cash Flow > change In Working Capital
34113000
Annuals > 2 > cash Flow > cash From Operations
4043000
Annuals > 2 > cash Flow > capital Expenditures
587000
Annuals > 2 > cash Flow > cash From Investing
9346000
Annuals > 2 > cash Flow > cash From Financing
283000
Annuals > 2 > cash Flow > net Change In Cash
9464000
Annuals > 2 > ratios > PE
-1.2307897641587402
Annuals > 2 > ratios > PB
0.5242650941422594
Annuals > 2 > ratios > ROE
-37.08391445839145
Annuals > 2 > ratios > ROA
-22.24647028063448
Annuals > 2 > ratios > FCF
3456000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.17822701253158682
Annuals > 2 > health Score
47
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
5000000
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
5000000
Annuals > 3 > income Statement > operating Expenses
49353000
Annuals > 3 > income Statement > operating Income
-44353000
Annuals > 3 > income Statement > interest Expense
625000
Annuals > 3 > income Statement > pretax Income
-45190000
Annuals > 3 > income Statement > net Income
-45347000
Annuals > 3 > income Statement > eps
-2.2951013325171985
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
19758169
Annuals > 3 > income Statement > income Tax Expense
157000
Annuals > 3 > income Statement > EBITDA
-43795000
Annuals > 3 > income Statement > operating Margin
-887.06
Annuals > 3 > income Statement > total Other Income Expense Net
-837000
Annuals > 3 > balance Sheet > cash
90869000
Annuals > 3 > balance Sheet > short Term Investments
42334000
Annuals > 3 > balance Sheet > receivables
734000
Annuals > 3 > balance Sheet > inventories
-48826648
Annuals > 3 > balance Sheet > total Current Assets
136505000
Annuals > 3 > balance Sheet > property Plant Equipment
1946000
Annuals > 3 > balance Sheet > total Assets
139247000
Annuals > 3 > balance Sheet > payables
2553000
Annuals > 3 > balance Sheet > short Term Debt
261000
Annuals > 3 > balance Sheet > long Term Debt
4284000
Annuals > 3 > balance Sheet > total Liabilities
20880000
Annuals > 3 > balance Sheet > equity
118367000
Annuals > 3 > cash Flow > net Income
-42355000
Annuals > 3 > cash Flow > depreciation
558000
Annuals > 3 > cash Flow > change In Working Capital
10837000
Annuals > 3 > cash Flow > cash From Operations
-28647000
Annuals > 3 > cash Flow > capital Expenditures
763999
Annuals > 3 > cash Flow > cash From Investing
-43545000
Annuals > 3 > cash Flow > cash From Financing
151160000
Annuals > 3 > cash Flow > net Change In Cash
75108453
Annuals > 3 > ratios > PE
-2.2951013325171985
Annuals > 3 > ratios > PB
0.2904459356070526
Annuals > 3 > ratios > ROE
-38.3105088411466
Annuals > 3 > ratios > ROA
-32.56587215523494
Annuals > 3 > ratios > FCF
-29410999
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-5.8821998
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.2672206178328051
Valuation > metrics > PB
3.6900403878902557
Valuation > final Score
43.09959612109744
Valuation > verdict
23.0% Overvalued
Profitability > metrics > ROE
-56.66982024597919
Profitability > metrics > ROA
-13.848376842308063
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.0929517502365185
Risk > metrics > Interest Coverage
-2517.6666666666665
Risk > final Score
-10065
Risk > verdict
High
Liquidity > metrics > Current Ratio
30.56831566548881
Liquidity > metrics > Quick Ratio
30.56831566548881
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-3626
Prev Risks > 1
-205
Prev Risks > 2
-25
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:47:57.775Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-19
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.24
Earnings History > 0 > eps Difference
0.24
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-13
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.27
Earnings History > 1 > eps Estimate
-0.245
Earnings History > 1 > eps Difference
-0.025
Earnings History > 1 > surprise Percent
-10.2041
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-13
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.32
Earnings History > 2 > eps Estimate
-0.3
Earnings History > 2 > eps Difference
-0.02
Earnings History > 2 > surprise Percent
-6.6667
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-19
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.1164
Earnings History > 3 > eps Estimate
-0.3745
Earnings History > 3 > eps Difference
0.2581
Earnings History > 3 > surprise Percent
68.9186
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-18
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.1297
Earnings History > 4 > eps Estimate
-0.2665
Earnings History > 4 > eps Difference
0.1368
Earnings History > 4 > surprise Percent
51.3321
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-14
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.4348
Earnings History > 5 > eps Estimate
-0.324
Earnings History > 5 > eps Difference
-0.1108
Earnings History > 5 > surprise Percent
-34.1975
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-20
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.31
Earnings History > 6 > eps Estimate
-0.36
Earnings History > 6 > eps Difference
0.05
Earnings History > 6 > surprise Percent
13.8889
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-21
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.02
Earnings History > 7 > eps Estimate
-0.12
Earnings History > 7 > eps Difference
0.1
Earnings History > 7 > surprise Percent
83.3333
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-20
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.24
Earnings History > 8 > eps Estimate
-0.12
Earnings History > 8 > eps Difference
-0.12
Earnings History > 8 > surprise Percent
-100
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-16
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.34
Earnings History > 9 > eps Estimate
-0.49
Earnings History > 9 > eps Difference
0.15
Earnings History > 9 > surprise Percent
30.6122
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-22
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.48
Earnings History > 10 > eps Estimate
-0.47
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-2.1277
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-06-08
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.53
Earnings History > 11 > eps Estimate
-0.52
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-1.9231
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-24
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.72
Earnings History > 12 > eps Estimate
-0.61
Earnings History > 12 > eps Difference
-0.11
Earnings History > 12 > surprise Percent
-18.0328
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-16
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
0.04
Earnings History > 13 > eps Estimate
-0.13
Earnings History > 13 > eps Difference
0.17
Earnings History > 13 > surprise Percent
130.7692
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-09-13
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.29
Earnings History > 14 > eps Estimate
-0.6
Earnings History > 14 > eps Difference
0.31
Earnings History > 14 > surprise Percent
51.6667
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-17
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.37
Earnings History > 15 > eps Estimate
-0.82
Earnings History > 15 > eps Difference
0.45
Earnings History > 15 > surprise Percent
54.878
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-24
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.33
Earnings History > 16 > eps Estimate
-0.36
Earnings History > 16 > eps Difference
0.03
Earnings History > 16 > surprise Percent
8.3333
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-15
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.27
Earnings History > 17 > eps Estimate
-0.31
Earnings History > 17 > eps Difference
0.04
Earnings History > 17 > surprise Percent
12.9032
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.28
Earnings History > 18 > eps Estimate
-0.27
Earnings History > 18 > eps Difference
-0.01
Earnings History > 18 > surprise Percent
-3.7037
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-20
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-12.27
Earnings History > 19 > eps Estimate
-0.81
Earnings History > 19 > eps Difference
-11.46
Earnings History > 19 > surprise Percent
-1414.8148
LAVA Therapeutics N.V. operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 which are preclinical candidates for the treatment of various hematologic malignancies. The company has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. LAVA Therapeutics N.V. was incorporated in 2016 and is based in Utrecht, the Netherlands.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALAVA Therapeutics (LVTX) Expected to Announce Earnings on Tuesday Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$1.5054
Analyst Picks
Strong Buy
1
Buy
0
Hold
3
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 32.43% of the total shares of LAVA Therapeutics NV
1.
Redmile Group, LLC(7.8858%)
since
2025/06/30
2.
BML Capital Management LLC(7.4913%)
since
2025/06/30
3.
Sanofi(7.2968%)
since
2025/06/30
4.
Merck & Co Inc(4.3693%)
since
2025/06/30
5.
Bruce & Co Inc(1.9839%)
since
2025/06/30
6.
Bruce(1.9839%)
since
2025/06/30
7.
Pathway Financial Advisors LLC(0.3897%)
since
2025/06/30
8.
PNC Financial Services Group Inc(0.2471%)
since
2025/06/30
9.
Citadel Advisors Llc(0.1969%)
since
2025/06/30
10.
BNP Paribas Arbitrage, SA(0.1783%)
since
2025/06/30
11.
Two Sigma Investments LLC(0.1308%)
since
2025/06/30
12.
UBS Group AG(0.0623%)
since
2025/06/30
13.
TWO SIGMA SECURITIES, LLC(0.0541%)
since
2025/06/30
14.
Geode Capital Management, LLC(0.0539%)
since
2025/06/30
15.
Fidelity Nasdaq Composite Index(0.0539%)
since
2025/07/31
16.
Morgan Stanley - Brokerage Accounts(0.0441%)
since
2025/06/30
17.
TSFG, LLC(0.0015%)
since
2025/03/31
18.
JONES FINANCIAL COMPANIES LLLP(0.0015%)
since
2025/06/30
19.
SBI Securities Co Ltd(0.0011%)
since
2025/06/30
20.
Millennium Management LLC(0%)
since
2025/03/31
21.
Atlantic Trust Group, LLC(0%)
since
2025/03/31
22.
Virtu Financial LLC(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.24
Date
2025-09-30
EPS Actual
-0.27
EPS Estimate
-0.245
EPS Difference
-0.025
Surprise Percent
-10.2041%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.